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Abstract --...--.. 
Objective-To define the benefit of rice oral 
ehydration salts solution in relation to the glucose 
z I===1 ased World Health Organisation oral rehydration 
F= salts solution for treating and preventing dehydration 
s sz in patients with severe dehydrating diarrhoea. 
e-~ .- - 
f=g 
1 
Design-Meta-analysis using data from 13 avail- 
C Eg 
able randomised trials that compared these two 
formulations. oi 0-r “-0 Subjects-The studies compared 1367 patients n- 
5s with cholera, severe cholera-like diarrhoea, or acute 
_c 
===rr non-cholera diarrhoea. 668 received the standard WHO solution and 699 the rice based solution. 
Intervention-Each trial report was reviewed to 
determine patient eligibility, the number of patients 
Medical Research Gnmcil, who were randomised and the number of these 
Biostatistics Unit, excluded from analysis, details of the randomisation 
Cambridge 
S M Gore, PHD, medical 
procedure, and the precise timing of the outcome 
measurements. 
sra1imiian Main outcome measures-Stool output dking the 
World Health lirst 24 hours; weighted estimates of the difference in 
Organisation, DiarrhoeaI mean stool output between treatments. 
Diseas”r Control Results-The rice solution significantly reduced 
programme, 1211 Geneva the rate of stool output during the first 24 hours by 
27, Swi&rtand 36% (95% confidence interval 28 to 44%) in adults 
Cl Fontaine, MD, medical with cholera and by 32% (19 to 45%) in children with 
oJ@er-, 
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cholera. The rate of stool loss in infants and children 
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with ac><e non-cholera diarrhoea was reduced by 
only’l8% (6 to 30%). 
Fontaine. 
E.M.7 1992;304:287-91 
Conclusions-The benefit of r+e oral rehydration 
salts solution for patients with cholera is sufficiently 
great to warrant its use in such patients. The benefit 
is considerably smaller for children with acute, non- 
cholera diarrhoea and should be more precisely 
defined before its practical value can be judged. 
Introduction 
Oral rehydration therapy with the glucose and 
electrolyte solution recommended by the World Health 
Organisation and Unicef is the preferred method for 
treating children with dehydration due to diarrhoea, 
provided that they are able to drink and do not have 
signs of shock.’ Although the solution is borh safe 
and effective (D Mahalanabis, unpublished WHO 
document), it has important limitations: it neither 
reduces the rate of stool loss nor shortens the duration 
of iitness.2~’ Mothers often do not understand the 
relation between diarrhoea and dehydration, and their 
primary concern, shared by many health workers, is to 
see the diarrhoea stop. This probably accounts for 
the continuing widespread use of ineffective “anti- 
diarrhoeal” drugs and antibiotics to treat diarrhoea 
instead of, or in addition to, oral rehydration salts 
solution (WHO diarrhoeal diseases control pro- 
gramme, seventh programme report, 1988-89, 1990). 
If a packaged oral rehydration salts formulation 
could be developed that not only had the positive 
features of the WHO formulation, including low cost 
and safety and stability during prolonged storage, but 
also substantially reduced the duration of diarrhoea or 
the rate of stool loss, it would have considerable 
advantages. In particular, it could be promoted as 
having a real antidiarrhoeal effect. This should improve 
its acceptance and.FFese--by both health workers and 
mothers, especial!y d Its benefits were sufficientI!: grrar 
to be evident to them. It might also result in less use of 
ineffective drugs and antibiotics. Such changes would 
represent a major advance in efforts to control morbid- 
ity and mortality associated with diarrhwa through 
effective case management. 
Several clinical trials have shown that an oral 
rehydration salts solution containing cooked rice 
powder (50-80 g/l) in place of the usual glucose (20 g/ l )  
substantially reduces the rate of stool loss due to acute 
Other studies, however, have reported no 
signifìcant The subjects in these studies 
varied considerably and included infants, children, 
and adults both with diarrhoea associated with cholera 
and with acute diarrhoea not associated with cholera. 
Moreover, in some studies the number of patients 
evaluated was probably insufficient to support firm 
conclusions. To define more precisely the true benefit 
of rice oral rehydration salts solution in relation to the 
WHO oral rehydration salts solution and to determine 
whether this benefit is related to the patient's age or the 
aetiology of diarrhoea we performed a meta-analysis by 
using data from all available randomised clinical trials 
that compared tbese two formulations. 
Methods 
SELECTION OF TRIALS 
Studies included in this overview were identified by 
a computer aided search of the published work, by 
reviewing the references cited in relevant repons, and 
by inquiring about completed but unpublished studies 
from our colleagues. Ten published and 
three unpublished ones (A M Moechtar, E Guiraldes, 
and N H Alam, personal communications) were 
identified and are reviewed in this analysis. On the 
basis of their design or method of analysis these 13 
studies yielded 17 comparisons between patient groups 
treated with rice oral rehydration salts or the WHO 
oral rehydration salts solution. Table I gives the 
principal features of each comparison. In all cases the 
studies were randomised uials that compared standard 
WHO oral rehydration salts solution with an experi- 
mental oral rehydration salts solution in which glucose 
(20g/l) was replaced by 50-80gfl of rice powder, 
the electrolyte concentrations remaining unchanged. 
In early studies (A N Alam, personal communi- 
cauon)"tl 13-ts the rice powder was cooked immediately 
before use and salts were added after the rice solution 
had cooled. In the most recen16I2 (Moechtar er al, 
Guiraldes et al) a commercially produced, precooked 
rice powder was prepackaged with oral rehydration 
salts, in sachets to make up one litre. This was 
TABLE r-characrerislics of Tandomised aialr of rice oral rehydrarim! sol& 
No randomid to 
Cholen (proponion Amount of rice in WHO1rice solution 
Comparison Age Dchydndon proved on culture) solution (gl) (No excluded) 
Patients d h  cholera or cholera-like illness 
Moechtar 
50 83/81 (010) er al (li' >12vean severe Ya 
Moechik 
Alam er al ( l ) t  Adults Moderate to severe 
Alam er a l  (2)t Adults Moderate to severe 
Molla er al (I I'* >IO yurs  Moderate to sevcre 
Molla er of (2)'* ?-< 10 years Modcrate to severe 
Molla er al (3)'' 1-5 ycars Moderarc to severe 
Molla (4)' 2-5 yean Moderate to severe 
A l m  (3)* 1-8 years Mcaieratc to w e r e  
Alam (4)" 1-8 Y ~ K  Moderate to severe 
Parra er aP 3 months-5 years Modentc to sevcrc 
Guiraldes er al 4-24 months Moderate 
Kenya er al" 4-59 months M+erari?o severe 
Durra er al" 4 months4 yean Moderare 
Bhan cl al" 3 months-5 years Moderate 
EI Mougi er al" 4-18 months Moderate 
,Aiohan rr al" 3 months-3 years ,%Id to severe 
er al (2). >I2 years Severe 
Paninrs 5 
NO 
Yes 
Yes 
Yes (65%) 
Yes (75%) 
Yes (55%) 
Y s  (80%) 
Yes (100%) 
WO 
Yes (30%) 
uirhout choltra 
No 
No 
No 
No 
No 
N O  
50 
50 
50 
80 
80 
50 
80 
50 
50 
50 
50 
60 
50 
50 
50 
50 
12/14(010) 
47/46 (?) 
42/47 (?) 
74/85 (UO) 
105184 (40) 
42/37 (?) 
25127 (010) 
19/20 (U21 
7/6 (010) 
26/26 (212) 
49151 (U2) 
50151 (111) 
33137 (010) 
3313 I (010) 
30130 (45) 
24/26 (113) 
prepared for use in the same way as standard WHO 
oral rehydration salts, as precooked rice dissolves A 
rapidly in cold water. 
To our knowledge no other randomised trials of 
these formulations of rice oral rehydration salts solution ., ' 
have been completed, although several are underway. 
We have not included three trials of solutions that 
contained only 30g/l of rice powder (O Fontaine, 
personal communication)" l6 and one of an oral rehy- 
dration salts solution containing rice powder and 
glycine." 
Each trial report was reviewed independently by a 
statistician (SMG) and a clinician (OF) to determine 
patient eligibility according to stated selection criteria 
for age and dehydration status; the number of patients 
who were randomised and the number of these sub- 
sequently excluded from analysis; details of the 
randomisation procedure; and the precise timing of the 
outcome measurements, such as stool output and 
intake of oral rehydration salts solution. 
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META-ANALYSIS 
Each of the 17 comparisons yielded an estimate of 
the true difference in mean stool output between 
patients treated with the two different salts solutions; 
and each difference in means (Di for comparison ij is 
qualified by a variance: 
var (Di)=(se,): li 
The larger the variance, the less precise is the 
observed difference as an estimate of the true difference 
in mean stool output between treatment groups. It 
follows that the amount of information conveyed by a 
single comparison about this true difference is inversely 
proportional to the variance of the estimated difference 
for that comparison. If the inverse of the variance is 
taken as a measure of the information contained in 
comparison i, then the weight (wi) that should be 
accorded to comparison i, among all comparisons in its 
set, may be taken to be the information in comparison i 
divided by the total information (that is, the sum 
over all comparisons i= 1,2,. . . n of the inverse of the ' ' 
variances): 
y = [( l/se#]Ei: I ( 
Clearly, these weights add up to one. A pooled or 
weighted estimate of the difference in mean stool 
output between patients treated with rice oral rehy- 
dration salts solution or WHO oral rehydration salts 
solution is obtained by summing the differences 
in individual comparisons, each multiplied by its 
corresponding weight, so that if a single comparison 
accounts for 10% of the information then 10% of 
its estimated difference counts towards the pooled 
estimate. With the foregoing choice of weights, the 
variance of the pooled difference has a particularly 
simple form. Just as we defined information as the 
inverse of variance, so the variance of the pooled 
estimate is the inverse of the total information: 
var (pooled difference)= var Ci: lwi Di= 1Ei: I (Use,): 
A 95% confidence interval for the pooled estimate 
nms from two standard errcm below the pooled 
estimate to two standard errors above, where the 
standard error is the square root of the variance of the 
pooled estimate. d 
Results 
EVALUATION OF TRIALS 
The review identified problems in both the design ' 
and the analysis of some trials. These are summarised 
below. +f 
Randmisation..f-' 
The rando'kisation of patients should have occurred 
~~ ~ 
'Single studies in which results werc stratified lor analysis. 
tClinical trial with a factoxdl &sign (4 cell trial). 
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TABLE I I  -Stool output in /LSI 24 h m r ~  in udullr &th diarrhoea associared m'th choka OT choka- l ike  illness 
Trament with WHO solution 
Man reduction ( v a r i a n e )  . Man(SD)stool Man stool outpur/ in stool output during 
'No analyvd taking output (g or mykg Man stool m a n  inrake of t rament  with rice 
Comparison WHOlrice solution in first 24 h) outputlSD solution solution (g or mvkg) Study weight 
\1 
J 
M a e c h r u  CI al (I) 6-24 hours 8318 I 133 (92) 1.4 0.63 39 (148) 0.45 
,Moechtar CI a l  (2) 6-24 h o u n  12/14 106(55) 1.9 0.63 48 (407) 0.16 
Alam CI  d ( l )  47/56 391 (157) 2.5 0.75 164(829) 0.08 
0% Alamrralf2) 42/47 366jl74) 2.1 0.8 I 
Molla CI ol( I)' 72/85 159!109) 1.5 064 .14 (266) 0.25 
144 (1068) 
TABLE 111-Stool output in fint 24 houn in children m'lh diarrhoea associnred un'th chokra orchokra-like illness 
Trament with WHO solution 
Mcan d u c t i o n  (variance) 
,Mean (SD) stool Man stool output/ in stool output during 
No d y x d  taking output (gor mvkg Man stwl m a n  inrake of trament with rice 
Comparison WHOlricc solution in b t  24 h) outpur/SD solution solution (g or mvkg) Study weight 
Molla ci  al (2)' 101184 204(140) 1.5 0.54 49 (362) 042 
Molla er al  (3)" 42/37 343(151) 2.3 I 4 9  181 (628) Zero 
M o l k  e l  al (4)' 25127 210 (158) 1.3 0.69 105 (1206) 0.12 
Alam CI al (3)* 19/20 290 (1%) 1.5 0.98 160 (2500) 0.06 
Alam CI  a l  (4)* 716 90 (75) 1.2 0.57 -40 (700) 0.2 I 
Pam CI U P  24/24 166(114) 1.5 062 69 (794) 0.19 
P 
'Data not reponed quantitatively; d u c s  in this able arc approximated from gnphic prcscnudon. 
TABLE 1v-Stool oulpur in fint 24 haas in children with d k r r h  MI assoriared wirh chokra 
Trearmcnt with WHO solution 
Mun reduction (variance) 
Man (SD) stool Man srool ourpilr/ in stool output during 
No analysed ou?ut (g or mvkg Man stml m a n  intake of uament with rice 
Comparison WHOlrice soluuon III fim 24 h) output/SD solution solution (gor mvkg) Study weight 
BMJ VOLUME 304 
Guiralds CI d 
Kenya ci al" 
Duna C I  al" 
Bhan CI aP 
El Mou@ CI op' 
M o b  CI al" 
48/49 126 (64) 2.0 OM 14 (219) 0.2 I 
49/50 103 (31) 3.3 0.48 3(35) Zero 
33/37 103 (55) 1.9 O60 17(145) . 0.32 
33/31 77 (58) 1.3 0.49 lO(161) 0.29 
23/23 110 (69) 1.6 22(340) . 014 
26/25 245 (129)* 1-9 0.72 82 (1115) 0.04 
T h e  reponed S D  (25.3) was very low in relation to the large observed difference in srool output; we assumed that the reponed SD viues were acrually SES 
and revised rhc SDS accordingly. 
' 
immediately before treatment with oral rehydration 
salts solution began-that is, after the completion of 
any intravenous treatment for severe dehydration. 
However, in no uial was it stated when patients with 
severe dehydration were randomised and outcome 
measurements iniriated-that is, before or after initial 
intravenous rehydration. Thus it was unclear whether 
the first 24 hour measurement of stool output began 
when intravenous rehydration was started or when oral 
rehydration salts solution was first given, as should 
have been the case. 
In one study patients were randomised irrespective 
of age, but were stratified into arbitrary age groups 
during analysis.' Ideally, such stratification should 
have been part of the randomisation plan. Stratification 
during analysis was also done in two other studies 
(Moechtar et a¡),? but this was based on aetiology and so 
was unavoidable. 
E x c l 4 f i o m  analysis 
Pragmatic analysis according to intention to treat 
requires that all randomised patients continue to be 
monitored and that their data be included in the 
analysis. Nevedeless,  in seven trials (Guiraldes e l  
a1)6191J.1s 1-15% of randomised patients were excluded 
from the analysis (table I), either because they were 
considered to be "treament failures" (usually because 
additional intravenous treatment was required) or 
because they had been randomised in error. In 
p o 3 r i a l s  that used a permuted blockla or factorial 
design (Alam er al) it seems that some patients were 
randomised but not reported on, as the numbers 
specified in the different treatment groups differed 
appreciably. The reasons for these differences were 
not stated. 
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Analysis and i n m l  consistency of ourcome aha 
Whereas all  studies reported stool output and oral 
rehydration salts solution intake during the first 24 
hours, few reported total stool output until diarrhoea 
stopped, and only seven studies reported the duration 
of diarrhoea. Our analysis therefore focused largely on 
stool output during the first 24 hours. The following 
results for the first 24 hours are reported: mean 
(standard deviation) stool output (in g or mykg body 
weight) for patients randomised to WHO oral rehy- 
dration salts solution; the ratio of mean stool output to 
its standard deviation; the ratio of mean stool output to 
mean intake of WHO oral rehydration salts solution; 
and the mean reduction in stool output (in g or d k g )  
for patients given rice oral rehydration salts solution 
compared with those given WHO oral rehydration 
salts solution, and the variance of that value. 
Tables II, III, and IV show the mean (SD) stool 
output (in g or mVkg) during the first 24 hours for 
patients in each study who were randomised to receive 
WHO oral rehydration salts solution. Whether the 
data were for adults with cholera or with cholera-like 
diarrhoea (severe dehydrating diarrhoea, clinically 
resembling that associated with cholera but from 
which Vibrio chkae  O 1  was not isolated) (table II), 
children with cholera or cholera-like diarrhoea (table 
III), or children with only acute non-cholera diarrhoea 
(table IV), the ratios of mean to standard deviation for 
stool output were roughly constant, averaging 1.6 and 
ranging (with one exception) from 1-2 to 2.5. This 
regularity indicates the need for logarithmic trans- 
formation; however, no study reported logarithmically 
rransformed data-cr performed calculations on that 
scale. This finc!.i& arso provides a criterion for judging 
the internal consistency of key outcome data. By this 
2 89 
- 
criterion one trial seems to be atypical with a ratio of 
3.3,,” twice the mean value reported in other studies. 
Even more extreme was the ratio of 10 from the data 
reported in another study.” We suspected confusion 
between standard error and standard deviation in this 
study, and therefore table IV shows what we believe to 
be the correct standard deviation for this trial, a value 
similar to those in the other studies. 
Tables II, III, and IV also show a second measure by 
which to assess the internal consistency of trial data- 
namely, the ratio of mean stool output to mean intake 
of WHO oral rehydration solution. Mean stool 
output averages about two thirds of mean oral rehy- 
dration salts solution intake. By this criterion one trial 
seems to be atvpical,1° the mean stool output being 
almost 50% &eater than the mean intake of oral 
rehydration salts solution (table III). In the.analyses 
that follow, two studies”’ I’ have been excluded (that is, 
zero weighted) for the reasons mentioned above. 
SUBSTANTIVE RESULTS 
The results of the analysis of stool output and intake 
of oral rehydration salts solutions during the first 24 
hours have been grouped into three sets according to 
the patient’s age and aetiology of diarrhoea, as shown 
in tables II, III, and IV. For the duration of diarrhoea 
all data have been combined, but comparisons in 
patients with suspected cholera who received tetra- 
cycline before diarrhoea stopped have been zero 
weighted (table V). 
Adults with cholera or cholera-like dzinrhoea-Table II 
shows the weights assigned to each of the five com- 
parisons in this set. By using these weights the 
estimated mean stool output for patients given WHO 
oral rehydration salts solution was 170 ml/kg. For 
patients given rice oral rehydration salts solution this 
was reduced by a mean of 58 ml/kg (36%, 95% 
confidence interval 28 to 44%). 
Children with cholera or cholera-like diarrhoea-Table 
III shows the weights assigned to each of the five 
comparisons in this set. One study15 was zero weighted 
for reasons described above. With those weights the 
estimated mean stool output for patients given the 
WHO oral solution was 178 ml/kg. For patients given 
the rice solution this was reduced by a mean of 48 tig 
(32%, 19% to 45%). 
Children with nun-cholpro diarrhoea- In this set of six 
comparisons, one study” was zero weighted for reasons 
described above (table IV). By using the weights 
calculated for the other five comparisons the estimated 
mean stool output for patients given the WHO solution 
was 107 ml/kg. For patients given the rice solution this 
was reduced by a mean of 18 ml/kg (18%; 6% to 30%). 
It is noteworthy that the esrimated mean percentage 
reduction in stool output associated with the rice 
solution in the zero weighted study is outside the 95% 
confidence interval derived from the other five studies. 
Overall reduction in stml output-The figure presents 
the percentage reduction in mean stool output (with 
TABLE v- Durarion of dkhoea 
Comparison 
Treatment with WHO soludon (Mean reduction 
No andyd (variance) duration of 
raking WHO/rice Mean (SD) No of Mevl diarrhoea with rice 
solution pC&IltS duration/SD solution Study weight 
P&chtas et 01(l)’ 
Moechtar et al (2)’ 
ALxmrral(1) 
AlamerLd(2) 
83181 
12114 
4714.5 
42147 
Ahm et a/ (3) 
Parra et ar 
mGh cholera 
24124 i 4 &h;faaT 2.1 I2 (109) 
24124 43 (22) 2.0 13 (36) 
Kenya et al” 49150 
Durta crol” 33137 
El Mougi CI al“ 26/25 
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Ad& wilh cholera 
39(11) 3.5 
36 (7) 5.1 
86 (22) 3.9 
85 (20) 4.2 
2 0) 
7(13) 
9 (26) 
4 (22) 
Children umhma cholera 
46 (9) 5.1 
79 (37) 2.i 
34(12) 2.8 
4 (4) 
IO (67) 
6(31) 
ZWO 
Z.30 
@23 
0.27 
0.05 
0.17 
Zero 
0.09 
0.19 
-80 -60 -40 -20 0 20 40 60 
Percentage reduction in stool output 
e reduction in 24 ham stool outpur in indkidual srudies 
cholera drimhoea given rice oral reh~dratum salts 
smol output 195% confidence intervali for each group of studies are 
sham in shaded box 
95% confidence intervals) for patients treated with the ‘* 
rice solution in each of the comparisons considered in 
this overview, as well as the pooled (weighted) estimates 
of the percentage reduction in mean stool output for 
patients with cholera (adults and children) and without 
cholera (details of these calculations are not shown). 
The effect of the rice solution on stool output was 
significantly less in children with non-cholera diarrhoea 
than in children and adults with cholera or cholera-like 
diarrhoea (95% confidence interval 39’0 to 310/o for the 
difference in percentage reduction in stool output 
in patients with cholera or cholera-like diarrhoea z, 
patients wi non-cholera diarrhoea). . 
Duration ofdian-hoea-Data from six comparisons,’ ’ 
including 
i 
th adults and children with cholera (who 
had not ret ived tetracycline before diarrhoea stopped j i 
and acute on-cholera diarrhoea were considered for 
this analysi (table V). The estimated mean duration in 
patients given the WHO oral rehydration solution was 
68 hours. For those given the rice solution the duration 
was reduced by a mean of eight hours (12%; 5% to 
19%). The 95% confidence interval excludes zero, 
indicaring a modest but significant reduction in the 
duration of diarrhoea. 
Discussion 
Irrespective of their age, patients with cholera who 
were given rice oral rehydration salts solution had 
substantial1 lower rates of stool loss than those who 
were given WHO oral rehydrarion salts solution. Stool 
volume was reduced by a mean of 48-58 ml/kg during 
ours of treatment, which was 32-3696 less 
reflects the fact that a greater amount of 
n an equimolar basis, 50-8Og/l of rice 
powder would release sufficient glucose and aminD 
acids to promote the absorption of all the sodium iand- 
water) in the rehydration solution and, in addition, 
reabsorption of at least part of the sodium (and water) 
secreted into the bowel as part of the diarrhoea1 
If process, thus diminishing stool output.‘” In contrast, 
the WHO solu ‘on contains only enough glucose (20 g/ 
K 1) to pr0rn:;e.t e absorption of the sodium and water in 
the solution, thus leaving the rate of stool loss essenti- 
ally unaffected.I9 The lower osmolarity of the rice 
solution (about 200 mmoVl 'D about 310 mmoYl) would 
also enhance the intesrinal absorption ofwater, but not 
of sodium.?@ 
In contrast with stool output in cholera patients, that 
in children with acute non-cholera diarrhoea was 
reduced by a mean of only 18 mllkg during the 6rst 24 
hours of treatment with rice solution-that is, by 18% 
compared with that in patients given the WHO 
solution. The significantly smaller benefit of the rice 
solution for these patients apparently reflects a partial 
failure of the process described above. The likely 
explanations are that, at least in some patients, rice 
starch and protein were not fully digested, thus 
reducing the amount of glucose and amino acids 
available to promote sodium absorption; or released 
glucose was not fully absorbed; or both. Failure to 
digest rice powder fully could reflect reduced amylase 
or disaccharidase activities related to young age, 
malnutrition, or mucosal damage by the infective 
Mucosal damage could also cause glucose 
malabsorption, which could exacerbate the rate of stool 
loss owing to the osmotic activiry of unabsorbed 
glucose in the bowel lumen. If this occurred the 
adverse effect would be greater for rice oral rehydration 
salts solution owing to the greater amount of glucose 
released when rice starch is fully hydrolysed. This 
meta-analysis affords no insight into which of these 
mechanisms explains the reduced effect of rice oral 
rehydration salts on stool loss in patients with acute 
non-cholera diarrhoea. 
The meta-analysis shows that treatment with rice 
solution reduces both the rate of stool loss and, to a 
lesser extent, the duration of diarrhoea, as compared . 
with treatment with the WHO solution. Both of these 
variables independently affect the total output of 
diarrhoeal stool during the illness. Thus when both are 
reduced the percenrage reduction in total stool output 
would be greater than the percentage reduction in 
either of the contributing measilrements. This suggests 
that total output of diarrhoeal stool would be the most 
important clinical outcome measure when different 
oral rehydration salts formulations are compared. 
Unformnately, this value was reported for only one 
study reviewed here6 and for another that compared 
a sorghum based oral rehydration salts solution 
with the WHO solution." In both studies the per- 
centage reduction was greater in total stool oucput 
than in either the rate of stool loss or duration of 
diarrhoea. 
The last point bears directly on whether the rice 
solution (or any other cereal based oral rehydration 
salts solution) would have sufiïcient advantage over the 
WHO solution to replace it in routine use at  health 
facilities, especially for treating children with acute 
non-cholera diarrhoea, who represent the overwhelm- 
ing majority of cases. The average 18% reduction in 
initial rate of stool loss, if applied to total stool output, 
is unlikely to justify the major effort and expense 
required to change over from glucose to precooked rice 
in the oral rehydration salts formulation, especially in 
developing countries. A crude esrimation showed that 
the current cost of commercially prepared oral rehy- 
dration salts based on precooked rice would be for each 
one litre packet about three times the cost of the 
standard packet of WHO oral rehydration salt packet. 
On the other hand, if the effect on total stool output is 
appreciably greater, owing to a concurrent shortening 
of illness, a change in oral rehydration salts formulation 
might be justified. This requires further study. In the 
meanrime the curent  data show that rice oral rehy- 
dration salts solution has enough advantage over the 
WHO oral rehydration salts solution to justify its use in 
patients with cholera, where this is convenient. . 
I Avcry .ME, Syndcr I D .  O d  therapy for acuic diarrhoea. The  undcruwd 
simple soluuon. N EnglJ.Hcd 1990;323:8914. 
2 Picrct N F ,  BamwcU IC. Mitn RC, Gnnasos  GJ, Reimou.iu RI ,  .Monda1 h. 
er al. Effect of mtngarrric glucowslectroly~c lnfusion upon water and 
clcctmlytc balancc m Asiatic cholcn. Gosmwnrrrologl 1%8;55:33343. 
3 Hirxhhorn N ,  Kinne J L ,  Sachar DB, Nonhrup  RS, Taylor JO. Ahmad SZ. er 
al. Dccrcasc in nct stool ouiput in cholcn dunng intestinal perfusion with 
glucox contauung soluuons. N Eng! J M c d  1%8:279:176-80. 
4 Mahalanabis D ,  S x k  RB, Jacobs B, Mondal A, Thomas J. Ux o i a n  ural- 
glucowilectrolytcsoluuonmIhctrcatmcntofpcdurnccholen: a conrrollrd 
sNdy. fmrmnl of TmpLaI Pdiomrs and Emromnnual Child Heolrh 
1974;20:82-7. 
5 Sack DA, Chowdhury AhL4K, Eusof A. Ali MA, .Mcrson .MH. Islam S. II d. 
O d  hydration ln rotavirus diarrhoea: a double-blind companson u¡ sucrox  
mth glucuxilectrolytc solution. Lancer 1978;Ü:280-3. 
6 Pam FC, Mahalanabis D ,  Jh KN, Scn A. Bancriee P. I s  oral nce clectrolw 
rolution supcnor to glucow clectrolyrc solution in mfanrde diarrhoea? .irch 
Du Ch& 1982;57:910-2. 
7 MOB AM, L r k c r  A. Molla A, Khatoon M. Grcenough WB I I I .  Riwbased 
o d  rehydrauon rhcnpy ~n acute d i a r r h w :  a supcnor therapy and a 
mcdium for calonc supplementauon. In: Eeckcls RE, Ransomc-Ruri O. 
Krooncntcrg CC, cds. Chd kdh UI rk "p"~. sisd .VvmrwC~xc m ~ '  (;*II 
synponwn, L m ,  18-21 Ocrobo 1983. Dordrecht, The Netherlands: 
Niihoff, 1985:65-70. 
8 Molln AM, Ahmed SM, Grccnough WB III. Ricc-bawd o d  rehydration 
solution decrease rhc stool volumc m acute diarrhoea. Bull WHO 
1985;63:751-6. 
9 Alam AN, Sarkcr SA, Molla AM, Maman MM, Greenough WB I I I .  
Hydrolysed wbat-bared o d  rchydnuon solution for acute diarrh+ca. .irch 
DL CMd l987;62:4#4. 
10 Molla AM, Narh SK, Molla A, Khatun M. Food bawd oral rehydntion d l 1  
solution for xutc childhood d i u r h w .  Lancrr 1989:1i:429-31. 
11 Bhan MK,  Chai OP, Kboshoo V, Vasudev AS, B h a m p  NK. Aron R, II JI. 
Efficacy of mung ban and pop ricc bawd o d  rchydntion solutions in 
compPrison with the standard g l u c m  clccrrolyte soluuon. f Prdmrr 
G c w " d  N u r  1987;6:392-9. 
12 Duna P, Durtn D, Bhartachvya SK, Sinha AK, Mondal BC. Pal SC. 
Comprative efficacy of b different o d  rchydnuon solu~tons for the 
uauncnt of dehydnung diarrhoea in chddrcn. lndlnnf Mad Res 1988.87: 
229-33. 
13 Mohan M, Antony TJ ,  Malik S, Mathur M. Ricc powder oral rehydration 
solution as an a l t c m u v e  IO d u c m  elecuol\~te solution. /dm 7 .Wed Res 
1988;81:234-9. 
14 Kenya PP, Odongo HW, W o  G, Waswa K, .Murrunga J. Molla A.\%. er 51 
Od b w d  o d  rchvdnuon roluuons. Arch Du Chdd 1989;s: 1032-5 
I S  El Moud M, H@ E, GAI O, El AkJud N,  El-Abhar A. Nour N. ZI ul .  
Conuollcd c l i n i d  trial on thc cffiucy of ricc powdcr.bared o d  rehydration 
solution on thc outcome of acute d i m h w  in infants.J Ptdurn Gernmrerol 
N u r  1988;7:5726. 
16 Mohan M, Sethi JS, D a n l  TS, Sharma M, Bhargava SK. Sachdcv HPS. 
ConvoUcd clinical uial of rice powder and glucose rehydration soluuons as 
o d  rhcnpy for acutc dchydnling diarrhoea m mfanrs. J Pedlnn Gamo- 
"¡Nur 1986;5:423-7. 
17 Pam FC, Mlbalanablr D, J h  KN, Maim T K ,  Scn A. Bancricc P. A 
conuollcd c l i n i d  rial of rice and g l y c i n c - c o n t m g  o d  rehydration 
solution for acute d i a r r h m  in children.J DkrtLxal  Dir Ra 1986:4: 16-9. 
18 Pam FC, Mahalanabis D, J h  KN, Scn A, Bancricc P. In search of a super 
solution: controllcd clinical rial of a glycinc-glucose oral rehydration 
solution in idanulcdiar rhaa .  ArlnPocdianScand 1984;73:18-21. 
19 Hirschhorn N. The t r a u n c n t  of acute diarrhoea m children: an historical and 
physiologid p c ~ p t i v e .  A m f  Clin Nun 1980;33:637-63. 
20 Wapnir RA, Zdanowicz M, Tcichberg S, Lifshitz F. Alanme stlmularion of 
 ter and sodium absorption in a model of mrcro13' diarrhwa. f Pedmn 
G a r d  N u r  1990;10:213-2 1. 
21 Lctcnthal E, Lev R, Ler PC. In: Lebenhl E, ed. Tcxrbook o f g ~ ~ n ~ ~ ~ l ~ r o l ~ g v  
andndmunrirmminfmrcy. Ncw York: h v c n  Press, 1981:14945. 
22 Lebenthal E, Hcidingcr L, Lec PC, Nord KS, H o d g ~  C, Brmks SP. George 
D. Corn syrup supn:  in v i m  and in wvo digcsubiliry and clinical tolerance 
in acutc diarrhoea of infancy.f Prdinn 1983;103:29-34. 
23 Veuluri T, Isolauri E. Clycioc supplcmcnrcd o d  rehydration soluiions for 
diurhw. Arch &Ch& 1986;61:372-6. 
24 Lcpagc P,  Hirimana DG, Vand Gocrhcm C, Ntahoruraba M, Nxngumuremyi 
F. Food bared o d  rchydntion u l t  solution for acute chddhood diarrhwa. 
Lancrr 1989;1i:868. 
(Accrpud I9 Nowmbrr1991) 
